UnitedHealth Group (NYSE:UNH) Shares Up 1.2% After Analyst Upgrade

UnitedHealth Group Incorporated (NYSE:UNH) was up 1.2% on Thursday after Raymond James Financial upgraded the stock from a market perform rating to an outperform rating. Raymond James Financial now has a $330.00 price target on the stock. UnitedHealth Group traded as high as $279.04 and last traded at $277.3040. Approximately 6,372,653 shares traded hands during trading, a decline of 34% from the average daily volume of 9,692,479 shares. The stock had previously closed at $273.98.

Several other research firms have also commented on UNH. Morgan Stanley dropped their target price on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a report on Friday, January 23rd. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Mizuho decreased their target price on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research note on Thursday, February 5th. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. Finally, Oppenheimer lowered their target price on shares of UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $363.38.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Raymond James upgraded UNH to Outperform (raised price target to $330), arguing management commentary points to bigger-than-expected margin improvement at Optum and upside to EPS estimates — a primary catalyst for the intraday move. Why Raymond James Says Wall Street Is Underestimating UnitedHealth’s Earnings Power
• Positive Sentiment: Market write-ups and trade notes highlighted the Raymond James view and framed UNH as a rebound candidate after a large multi-quarter pullback, driving short-term buying interest. Why UnitedHealth Stock (UNH) Is Rising Today — And What Raymond James Sees Next
• Positive Sentiment: Several analysts and outlets reiterated that UNH’s earnings surprise history and cost/margin opportunities make another beat likely, supporting medium-term upside expectations. Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report?
• Positive Sentiment: Feature pieces pitching UNH as a long-term wealth compounder and buy-the-dip narratives (including analyst calls to buy after the recent decline) are attracting retail and institutional attention. UnitedHealth Group (UNH): One of the Stocks That Can Make You Richer in 2026
• Neutral Sentiment: Social and forum discussion surged after shares dipped below Berkshire’s purchase price, fueling both bargain-hunting and volatility debates — a mixed factor that can amplify moves in either direction. UnitedHealth Group Stock (UNH) Opinions on Plunge Below Buffett Purchase Price
• Negative Sentiment: Leerink flagged material RADV audit exposure as a significant headwind — a reminder that Medicare Advantage reimbursement audits and regulatory scrutiny remain a key downside risk for valuation. Leerink sees UnitedHealth stock facing largest RADV audit exposure
• Negative Sentiment: The Ninth Circuit is set to hear whether UNH’s broad preemption defense shields it from certain liabilities — a potential legal risk that could increase exposure if the court rules against the company. Ninth Circuit to Decide if UnitedHealth Keeps Its Preemption “Get-Out-of-Jail-Free” Card – GJLaw

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Norges Bank acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $4,376,167,000. Capital Research Global Investors boosted its stake in UnitedHealth Group by 126.9% during the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock worth $4,503,419,000 after purchasing an additional 7,293,009 shares during the last quarter. Berkshire Hathaway Inc acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $1,572,193,000. Dodge & Cox lifted its stake in shares of UnitedHealth Group by 117.7% in the second quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock worth $2,729,912,000 after buying an additional 4,730,192 shares in the last quarter. Finally, Capital World Investors grew its stake in UnitedHealth Group by 18.8% during the 3rd quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock valued at $7,516,107,000 after acquiring an additional 3,439,182 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79. The stock’s 50 day simple moving average is $286.16 and its two-hundred day simple moving average is $320.70. The firm has a market capitalization of $251.70 billion, a PE ratio of 21.02, a price-to-earnings-growth ratio of 1.24 and a beta of 0.40.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $2.09 by $0.02. The firm had revenue of $113.73 billion during the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the firm earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a yield of 3.2%. UnitedHealth Group’s payout ratio is 67.02%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.